alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Form of Note


 


	$__________________	December 3, 2012
 



 


The undersigned ("Borrowers"),
for value received, promises to pay to the order of _____________ ("Lender") at the principal office of Atalaya
Administrative LLC ("Administrative Agent") in New York, New York the aggregate unpaid amount of all Loans made
to Borrowers by Lender pursuant to the Credit Agreement referred to below, such principal amount to be payable on the dates set
forth in the Credit Agreement.


 


Borrowers further promise
to pay interest on the unpaid principal amount of each Loan from the date of such Loan until such Loan is paid in full, payable
at the rate(s) and at the time(s) set forth in the Credit Agreement. Payments of both principal and interest are to be made in
lawful money of the United States of America.


 


This Note evidences
indebtedness incurred under, and is subject to the terms and provisions of, the Credit Agreement, dated as of December 3, 2012
(as amended, restated or otherwise modified from time to time, the "Credit Agreement"; terms not otherwise defined
herein are used herein as defined in the Credit Agreement), among Borrowers, the financial institutions (including Lender) party
thereto from time to time and Administrative Agent, as administrative agent for such financial institutions, to which Credit Agreement
reference is hereby made for a statement of the terms and provisions under which this Note may or must be paid prior to its due
date or its due date accelerated.


 


This Note is made under
and governed by the laws of the State of New York applicable to contracts made and to be performed entirely within such State.


 


	 	OPTOS CAPITAL PARTNERS, LLC, as Parent and a
	 	Borrower
	 	 
	 	By:	Focus Venture Partners, Inc., its
	 	 	sole Member and Manager
	 	 
	 	 	By:	 
	 	 	 	Christopher Ferguson
	 	 	 	President
EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection  with the Quarterly  Report on Form 10-Q/A of WNC Housing Tax
Credit Fund VI, L.P.,  Series 6 (the  "Partnership")  for the quarter ended June
30, 2003 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"),  and pursuant to 18 U.S.C., section 1350, as adopted pursuant to
section  906 of the  Sarbanes-Oxley  Act of  2002,  I,  Thomas  J.  Riha,  Chief
Financial Officer of WNC & Associates, Inc., general partner of the Partnership,
hereby certify that:

     1.   The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     2.   The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Partnership.




/s/THOMAS J. RIHA
-----------------
Thomas J. Riha
Chief Financial Officer of WNC & Associates, Inc.
October 12, 2005
|   | I, Toni M. Perazzo, certify that: |
|--------|-----------------------------------|

|   | 1.  I have reviewed this report on Form 10-Q/A of AeroCentury Corp.; and |
|--------|------------------------------------------------------------------------------------|

|   | 2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                               |   |                                           |
|------------------------------------|--------|------------------------------------------------|
|                               |   |                                           |   |
| Date:  February 14, 2011 | By:    | /s/ Toni M. Perazzo                       |   |
|                               |   | Name: Toni M. Perazzo                          |   |
|                               |   | Title: SVP Finance and Chief Financial Officer |   |
|                               |   |                                           |   |
#### Clifton P. PENNINGTON, Jr., Plaintiff-Appellant, v. Larry G. MASSANARI, Acting Commissioner of Social Security Administration, Defendant-appellee.

No. 01-1096.

United States Court of Appeals, Fourth Circuit.

Submitted June 8, 2001.

Decided June 28, 2001.

Erick A. Bowman, Wolfe *&*Farmer, Norton, VA, for appellant. James A. Winn, Regional Chief Counsel, Region III, Patricia M. Smith, Deputy Chief Counsel, Mona M. Bennett, Assistant Regional Counsel, Office of the General Counsel, Social Security Administration, Philadelphia, PA; Robert P. Crouch, Jr., United States Attorney, Julie C. Dudley, Assistant United States Attorney, Roanoke, VA, for appellee.

Before WIDENER, NIEMEYER, and GREGORY, Circuit Judges.

PER CURIAM.

Clifton Pennington appeals the district court’s order upholding the Commissioner’s denial of his claim for disability insurance benefits. Pennington worked in the coal mining industry until he quit on February 15, 1995, because of groin and back pain. Finding substantial evidence to support the Administrative Law Judge’s determination that Pennington was physically capable of performing the full range of light work, did not suffer from a severe mental impairment, and was not disabled within the meaning of the Social Security Act, we affirm on the reasoning of the district court. *See Hays v. Sullivan,*907 F.2d 1453, 1456 (4th Cir.1990). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed).                    

*Date:*                         November 13-15, 2023.                    

*Time:*                         9:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G53, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Caitlin A. Brennan, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G53, Rockville, MD 20852, (301) 761-7792,                         *caitlin.brennan2@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: September 20, 2023.

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-20875 Filed 9-25-23; 8:45 am]

BILLING CODE 4140-01-P
No. 66472.

#### Carlyle Fabrics *v.*United States,

protests 305501-K, etc. (New York).

Opinion by

Rao, J.

In accordance with stipulation of counsel that the merchandise consists of waterproof cotton cloth similar in all material respects to that the subject of *United States*v. *D. H. Grant & Co., Inc.*(47 C.C.P.A. 20, C.A.D. 723), the claim of the plaintiff was sustained.
Exhibit 32.2

Statement





Pursuant to §906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. §1350, the undersigned officer of Luxemburg Bancshares, Inc. (the Company), hereby certifies that to the knowledge of the undersigned:



(1)

the Companys Quarterly Report on Form 10-Q for the quarter ended September 30, 2003 fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

(2)

the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Dated:  November 5, 2003





/s/ Sheri L. Knope

Sheri L. Knope

Chief Financial Officer





A signed original of this written statement required by Section 906 has been provided to Luxemburg Bancshares, Inc. and will be retained by Luxemburg Bancshares, Inc. and furnished to the Securities and Exchange Commission upon request.  This statement accompanies the periodic report to which it relates and shall not be deemed as filed as part of the report or otherwise for purposes of the Securities Exchange Act of 1934.
UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549








FORM 8-K





CURRENT REPORT





Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934





DATE OF REPORT (Date of earliest event reported): December 21, 2016





CATERPILLAR FINANCIAL SERVICES CORPORATION


(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)





Delaware (STATE OR OTHER JURISDICTION OF INCORPORATION)001-11241 (COMMISSION FILE NUMBER)37-1105865 (IRS EMPLOYER IDENTIFICATION NUMBER)





2120 West End Avenue, Nashville, Tennessee    37203-0001 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)    (ZIP CODE)


Registrant’s telephone number, including area code: (615) 341-1000





Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)





o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)





o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))





o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

















---







I tem 8.01 Other Events .


Exhibits are filed herewith in connection with the issuance on December 21, 2016 by Caterpillar Financial Services Corporation (the “Company”) of $200,000,000 aggregate principal amount of its Medium-Term Notes, Series H, Floating Rate Notes due 2018 (the “Notes”) pursuant to the Company’s previously filed Registration Statement on Form S-3 (Registration No. 333-195039) (the “Registration Statement”) and the related Prospectus dated April 4, 2014, Prospectus Supplement dated April 4, 2014 and Pricing Supplement dated December 16, 2016, relating to the Notes.





Item 9.01. Financial Statements and Exhibits .





(d) Exhibits . The following Exhibits are filed as part of this Report and as Exhibits to the Registration Statement:





ExhibitNumberDescription5.1Opinion of Sidley Austin LLP, as to the legality of the Notes.23.1Consent of Sidley Austin LLP (included as part of Exhibit 5.1).











2


---







SIGNATURE





Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.





Caterpillar Financial Services CorporationBy:/s/ Leslie S. ZmuggName: Leslie S. Zmugg Title:   Secretary





Date: December 21, 2016











3


---







EXHIBIT INDEX








ExhibitNumberDescription5.1Opinion of Sidley Austin LLP, as to the legality of the Notes.23.1Consent of Sidley Austin LLP (included as part of Exhibit 5.1).








4
Before the Second Division,

August 23, 1961

No. 65971.

#### Heinrich, Hermann & Weiss *v.*United States,

protest 60/3948 (New York).

Opinion by

Lawrence, J.

In accordance with stipulation of counsel that the merchandise consists of traveling irons similar in all material respects to those the subject of *Greatrex, Limited,*and *J. J. Gavin & Co., Inc.*v. *United States*(33 Cust. Ct. 79, C.D. 1639), the claim of the plaintiff was sustained.
Unassociated Document












 


Consent of Independent Registered Public Accounting Firm







We consent to the reference to our firm under the caption “Experts” and to the use of our reports dated December 21, 2012, in the Registration Statement (Form S-1 No. 333-168227) of Direxion Shares ETF Trust II dated December 21, 2012 to be filed on or around December 21, 2012.






















New York, NY


December 21, 2012
[Federal Register Volume 88, Number 182 (Thursday, September 21, 2023)]
[Notices]
[Pages 65181-65182]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20436]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Human Liver and Human 
Liver Cells Research Resource.
    Date: November 17, 2023.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, NIDDK, Democracy II, Suite 
7000A, 6707

[[Page 65182]]

Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Maria E. Davila-Bloom, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural 
Activities, National Institutes of Health, National Institute of 
Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 
7000A, 6707 Democracy Boulevard, (301) 594-7637, <a href="/cdn-cgi/l/email-protection#badedbccd3d6db97d8d6d5d5d7d7fadfc2cec8db94d4d3deded194d4d3d294ddd5cc"><span class="__cf_email__" data-cfemail="167277607f7a773b747a79797b7b56736e62647738787f72727d38787f7e38717960">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: September 15, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-20436 Filed 9-20-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
CATERPILLAR FINANCIAL SERVICES CORPORATION

POWERNOTES (SM)

With Maturities of 9 months or more from Date of Issue


Registration No.  333-35460
Filed Pursuant to Rule 424 (b) (2)
PRICING SUPPLEMENT NO.  057				Trade Date: 03/15/01
(To Prospectus Supplement & Prospectus dated
  September 8, 2000)						Issue Date:  03/20/01
The Date of this Pricing Supplement March 15, 2001

SUBJECT TO REDEMPTION
OR REPAYMENT
  CUSIP									Date and terms of redemption or
     or	Stated				             Interest			repayment (including any
Common	Interest		  Price to	 Discounts &         Payment	Survivor's		applicable
                                                           regular or special
  Code	Rate (1)	Maturity	Public (2)	Commissions       Frequency	  Option	Yes/No
                                                                 	record dates)

14911QCJ8	   5.5%	03/15/05	100%	        1.0%      Monthly	      YES	    NO



Original Issue Discount Note:					Total Amount of OID:
____  Yes	  X   No						N/A



(1) The interest rates on the PowerNotes (SM) may be changed by Caterpillar
Financial Services Corporation from time to time, but any such change will not
affect the interest rate on any PowerNotes (SM) offered prior to the
effective date of the change.

(2) Expressed as a percentage of aggregate principal amount.  Actual Price to
Public may be less, and will be determined by prevailing market prices at the
time of purchase as set forth in the confirmation sheet.
-80 -78 -76 -74 -72

 38

 40

 42

★ ▲

▲

▲

▲

★

▲

▲

▲ ▲

 500

 1000

 1500

 100

18 12 06 00

05/28

NOAA HYSPLIT MODEL

 Backward trajectory ending at 2300 UTC 28 May 06

 EDAS Meteorological Data

Source

★ at 38.77 N 77.11 W Meters AGL
From: ssmuelle@tnics.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:37:11 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Scott Mueller

Milbank, SD 57252
TABLE 70. TURKEY FRESH MANURE CHARACTERISTICS*

====================================================================================== Parameter Units a Total Parameter Concentration Parameter Mass No of ------------------------------------------------------------------ -------------lb/day/----------- Observ minimum maximum median mean std dev bird 1000 lb

------------------------------------------------------------------------------------------------------------------------------- ------------------------------------- Manure b lb/15 lb/day 18 0.32 0.96 0.65 0.68 0.15 0.68 45 Density lb/ft 3 4 63 65 63 63 0.99 - - TS %wb 21 19 31 25 25 2.6 0.17 11 TSS %db 1 57 57 57 57 - 0.10 6.5 VS %db 7 62 89 82 77 11 0.13 8.8 BOD 5 mg/kg 7 35948 75980 56667 58668 12720 0.040 2.7 COD mg/kg 6 172667 282328 251741 235612 48499 0.16 11 OM mg/kg 1 22172 22172 22172 22172 - 0.015 1.0 pH 2 6.7 6.7 6.7 6.7 0 - - TKN lb/ton 20 20 36 27 28 4.5 0.0095 0.63 NH 3 N %tkn 4 9.9 45 30 29 16 0.0027 0.18 P 2 O 5 lb/ton 23 9.6 46 22 24 10 0.0083 0.55 K2 O lb/ton 22 5.0 19 12 12 4.1 0.0041 0.27 B lb/ton est c - - - 0.055 - 0.000019 0.0012 Ca lb/ton 4 12 47 24 27 15 0.0092 0.61 Cd lb/ton est - - - 0.0012 - 0.00000041 0.000027 Cl lb/ton est - - - 20 - 0.0069 0.46 Cu lb/ton 3 0.025 0.035 0.032 0.031 0.0044 0.000010 0.00069 Fe lb/ton 2 2.0 4.4 3.2 3.2 1.2 0.0011 0.073 Mg lb/ton 3 2.8 3.5 3.0 3.1 0.30 0.0011 0.070 Mn lb/ton 2 0.089 0.12 0.10 0.10 0.014 0.000035 0.0023 Mo lb/ton est - - - 0.0092 - 0.0000031 0.00021 Na lb/ton 3 2.4 3.5 2.5 2.8 0.51 0.0010 0.063 Ni lb/ton est - - - 0.0076 - 0.0000026 0.00017 Pb lb/ton est - - - 0.023 - 0.0000078 0.00052 S lb/ton est - - - 3.1 - 0.0011 0.071 Zn lb/ton 3 0.23 1.4 0.26 0.62 0.53 0.00021 0.014 FC cols/100 gm 1 2.90E+07 2.90E+07 2.90E+07 2.90E+07 - 8.93E+07 5.95E+09

====================================================================================== * References:Biological & Agricultural Engineering Dept, North Carolina State University, Jan 1994. Agronomic Division, North Carolina Department of Agriculture & Consumer Services.

a All concentrations as is or wet basis (wb) except as noted dry matter basis (db); all mass values wb. b Feces and urine as voided.
cMean value extrapolated from other data; measured values not available. 

### Turkery-Fresh Manure file:///G:/Share/EMRAD 2007-2011/2011/4-30/References/Biomass - M...

1 of 1 1/13/2011 11:58 A M
No. 60984.

protest 82007-K (New York).

#### Steinhardter & Nordlinger *v.*United States,

Opinion by

Donlon, J.

In accordance with stipulation of counsel that the merchandise consists of bitter orange pulp the same in all material respects as that passed upon in *T. M. Duche & Sons, Inc., et al.*v. *United States*(44 C. C. P. A. 60, C. A. D. 638), the claim of the plaintiff was sustained.